Genetics in renal cell carcinoma

Current Opinion in Urology

Volumn 13, Issue 6, 2003, Pages 463-466

  Dal Cin, Paola ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Cytogenetics Laboratory   (United States)

Author keywords

Chromosome 3; Familial renal cell carcinoma; Gene expression profiles; Loss of heterozygosity; Renal cell carcinoma; Tumor suppressor gene

Indexed keywords

CANCER GENETICS; CHROMOSOME; CORRELATION ANALYSIS; CYTOGENETICS; DISEASE MARKER; FAMILIAL CANCER; GENE EXPRESSION; HISTOLOGY; HUMAN; KIDNEY CARCINOMA; KIDNEY COLLECTING TUBULE; MOLECULAR GENETICS; MORPHOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

CARCINOMA, RENAL CELL; GENE EXPRESSION PROFILING; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 0442276328     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200311000-00007     Document Type: Review

References (25)

1. Fleming S, O'Donnell M. Surgical pathology of renal epithelial neoplasms: recent advances and current status. Histopathology 2000; 36:195-202.
2. Kovacs G, Akhtar M, Beckwith BJ, et al. The Heidelberg classification of renal cell tumours. J Pathol 1997; 183:131-133.
3. Storkel S, Eble JN, Adlakha K, et al. Classification of renal cell carcinoma: workgroup no. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997; 80:987-989.
4. Takahashi M, Rhodes DR, Furge KA, et al. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci USA 2001; 98:9754-9759.
5. Higgins JP, Shinghal R, Gill H, et al. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol 2003; 162:925-932. This article identifies a gene expression signature for each subtype of RCC and also for normal kidney. Moreover, the authors suggest a possibility for revised classification of renal tumors.
6. Young AN, de Oliveira Salles PG, Lim SD, et al. Beta defensin-1, parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays. Am J Surg Pathol 2003; 27:199-205. This study shows the utility of gene expression profiling for diagnostic molecular markers used in differential diagnosis and to support the current model of renal tumor histogenesis.
7. van den Berg A, Buys CHCM. Involvement of multiple loci on chromosome 3 in renal cell cancer development. Genes Chromosom Cancer 1997; 19:59-76.
8. Alimov A, Kost-Alimova M, Liu J, Li C, et al. Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma. Oncogene 2000 9; 19:1392-1399.
9. Bodmer D, van den Hurk W, van Groningen JJ, et al. Understanding familial and non-familial renal cell cancer. Hum Mol Genet 2002; 11:2489-2498. This article reviews the critical role(s) of multiple genes on chromosome 3 in the development of conventional RCC in familial and non-familial cases. The authors discuss the risk for RCC development in families with a constitutional chromosome 3 translocation, involving the proximal p-and q-arms of the centromere.
10. Martinez A, Fullwood P, Kondo K, et al. Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis. Mol Pathol 2000; 53:137-144
11. Morrissey C, Martinez A, Zatyka M, et al. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both dear cell and papillary renal cell carcinoma. Cancer Res 2001; 61:7277-7281.
12. Velickovic M, Delahunt B, Storkel S, Grebem SK. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance. Cancer Res 2001; 61:4815-4819.
13. Burget P, Kovacs G. Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis. Am J Pathol 1996; 149:2081-2088.
14. Sukosd F, Kuroda N, Beothe T, et al. Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma. Cancer Res 2003; 63:455-457.
15. Fischer J, Palmedo G, von Knobloch R, et al. Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours. Oncogene 1998; 17:733-739.
16. Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 1997; 10:537-544
17. Jiang F, Richter J, Schraml P, et al. Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes. Am J Pathol 1998; 153:1467-1473.
18. Sanders ME, Mick R, Tomaszewski JE, Barr FG. Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma. Am J Pathol 2002; 161:997-1005.
19. Lubensky IA, Schmidt L, Zhuang Z, et al. Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype. Am J Pathol 1999; 155:517-526.
20. Sidhar SK, Clark J, Gill S, et al. The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet 1996; 5:1333-1338.
21. Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 2001; 159:179-192.
22. van Kessel AG, Wijnhoven H, Bodmer D, et al. Renal cell cancer: chromosome 3 translocations as risk factors. J Natl Cancer Inst 1999; 91:1159-1160.
23. Gemmill RM, West JD, Boldog F, et al. The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8. Proc Natl Acad Sci U S A; 1998; 95:9572-9577.
24. Bodmer D, Eleveld M, Kater-Baats E, et al. Disruption of a novel MFS transporter gene, DIRC2, by a familial renal cell carcinoma-associated t(2;3)(q35;q21). Hum Mol Genet 2002; 11:641-649.
25. Toro JR, Nickerson ML, Wei MH, et al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 2003; 73:95-106. The study expands the histologic spectrum of renal tumors and FH mutation associated with hereditary leiomyomatosis and renal cell cancer.